Skip to content

Osteoporosis Disease Management Demonstration Project (0000-040)

Three Methods of Delivering Health Care for Secondary Prevention of Osteoporosis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00145067
Enrollment
230
Registered
2005-09-05
Start date
2003-11-30
Completion date
2006-06-30
Last updated
2015-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Brief summary

The purpose of the study is to evaluate the impact disease management interventions in treatment compliance among post-fracture and osteoporosis patients.

Interventions

Sponsors

Merck Sharp & Dohme LLC
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Members of of the Kaiser Permanente Health Plan who have fractured a bone.

Exclusion criteria

* Individuals who are not members of the Kaiser Permanente Health Plan.

Design outcomes

Primary

MeasureTime frame
Treatment persistence

Secondary

MeasureTime frame
Patient satisfaction and knowledge

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026